Last updated on March 2018

A clinical trial to evaluate treatments using Saxagliptin, Placebo to match saxagliptin, Sitagliptin, Placebo to match sitagliptin for patients with NIDDM, Heart failure

Brief description of study

This is a 24 week, multicenter, randomized, double-blind, parallel group, placebo-controlled study to investigate the effects of saxagliptin and sitagliptin on cardiac dimensions and function in patients with type 2 diabetes (T2DM) mellitus and heart failure (HF).

Clinical Study Identifier: NCT02917031

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )